Viridian Therapeutics, Inc.\DE (VRDN)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch VRDN
See up to 3 months of VRDN. The 7-day demo opens the 1M and 3M ranges and puts VRDN on your watchlist.
Start 7-day demoLatest VRDN insider trades
Jennifer Tousignant - OfficerOpen-market sale$103K- Jennifer Tousignant - OfficerOpen-market sale$245K
About Viridian Therapeutics, Inc.\DE (VRDN)
Viridian Therapeutics, Inc.\DE files with the SEC under CIK 0001590750 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
VRDN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 14,212 | $348K |
| Option exercise | 4 | 100,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VRDN insider transactions (Form 4)
4726 Form 4 filings on record, the earliest from Jul 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jennifer Tousignant - Officer | Open-market sale | Common Stock | 4,212 footnote F1 | $24.50 | $103K | |
| Jennifer Tousignant - Officer | Option exercise | Common Stock | 10,000 | $14.41 | $144K | |
| Jennifer Tousignant - Officer | Open-market sale | Common Stock | 10,000 | $24.50 | $245K | |
| Jennifer Tousignant - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| ||||||
| Radhika Tripuraneni - Officer | Option exercise | Common Stock | 40,000 | $13.21 | $528K | |
| Radhika Tripuraneni - Officer | Option exercise | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Christopher W. Cain | Grant or award | Stock Option (Right to Buy) | 32,341 | $0.00 | - | |
 Jeffrey Robert Ajer | Grant or award | Stock Option (Right to Buy) | 32,341 | $0.00 | - | |
| Jennifer K. Moses | Grant or award | Stock Option (Right to Buy) | 32,341 | $0.00 | - | |
 Sarah Gheuens | Grant or award | Stock Option (Right to Buy) | 32,341 | $0.00 | - | |
| Tomas Kiselak | Grant or award | Stock Option (Right to Buy) | 32,341 | $0.00 | - | |
| Arlene Morris | Grant or award | Stock Option (Right to Buy) | 32,341 | $0.00 | - | |
| Fairmount Funds Management LLC - Director | Open-market purchase | Common Stock | 1,176,470 | $17.00 | $20.00M | |
| Seth Harmon - Officer | Tax withholding / forfeiture | Common Stock | 2,031 | $30.19 | $61K | |
| Thomas W. Beetham - Officer | Tax withholding / forfeiture | Common Stock | 3,048 | $30.19 | $92K | |
| Jennifer Tousignant - Officer | Tax withholding / forfeiture | Common Stock | 1,675 | $30.19 | $51K | |
| Stephen F. Mahoney - Officer | Tax withholding / forfeiture | Common Stock | 7,408 | $30.19 | $224K | |
| Jennifer Tousignant - Officer | Grant or award | Restricted Stock Units | 23,850 | $0.00 | - | |
| Jennifer Tousignant - Officer | Option exercise | Restricted Stock Units | 5,169 | $0.00 | - | |
| Jennifer Tousignant - Officer | Tax withholding / forfeiture | Common Stock | 1,724 | $29.32 | $51K | |
| Jennifer Tousignant - Officer | Option exercise | Common Stock | 5,169 | - footnote F2 | - | |
| Jennifer Tousignant - Officer | Grant or award | Stock Option (Right to Buy) | 119,300 | $0.00 | - | |
| ||||||
| Seth Harmon - Officer | Grant or award | Restricted Stock Units | 20,550 | $0.00 | - | |
| Seth Harmon - Officer | Option exercise | Restricted Stock Units | 6,267 | $0.00 | - | |
| Seth Harmon - Officer | Option exercise | Common Stock | 6,267 | - footnote F2 | - | |
| Seth Harmon - Officer | Tax withholding / forfeiture | Common Stock | 2,091 | $29.32 | $61K | |
| Seth Harmon - Officer | Grant or award | Stock Option (Right to Buy) | 102,850 | $0.00 | - | |
| ||||||
| Thomas W. Beetham - Officer | Option exercise | Common Stock | 9,409 | - footnote F2 | - | |
| Thomas W. Beetham - Officer | Tax withholding / forfeiture | Common Stock | 3,138 | $29.32 | $92K | |
| Thomas W. Beetham - Officer | Grant or award | Stock Option (Right to Buy) | 176,550 | $0.00 | - | |
| Thomas W. Beetham - Officer | Grant or award | Restricted Stock Units | 35,300 | $0.00 | - | |
| Thomas W. Beetham - Officer | Option exercise | Restricted Stock Units | 9,409 | $0.00 | - | |
| ||||||
| Stephen F. Mahoney - Officer | Option exercise | Common Stock | 18,357 | - footnote F2 | - | |
| Stephen F. Mahoney - Officer | Tax withholding / forfeiture | Common Stock | 7,627 | $29.32 | $224K | |
| Stephen F. Mahoney - Officer | Grant or award | Stock Option (Right to Buy) | 559,600 | $0.00 | - | |
| Stephen F. Mahoney - Officer | Grant or award | Restricted Stock Units | 111,900 | $0.00 | - | |
| Stephen F. Mahoney - Officer | Option exercise | Restricted Stock Units | 18,357 | $0.00 | - | |
| ||||||
| Radhika Tripuraneni - Officer | Grant or award | Restricted Stock Units | 19,150 | $0.00 | - | |
| Radhika Tripuraneni - Officer | Grant or award | Stock Option (Right to Buy) | 95,800 | $0.00 | - | |
| Jennifer Tousignant - Officer | Open-market sale | Common Stock | 2,272 | $31.16 | $71K | |
| Fairmount Funds Management LLC - Director | Open-market purchase | Common Stock | 454,545 | $22.00 | $10.00M | |
| Christopher W. Cain | Grant or award | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Tomas Kiselak | Grant or award | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Sarah Gheuens | Grant or award | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Jennifer K. Moses | Grant or award | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Jeffrey Robert Ajer | Grant or award | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
| Arlene Morris | Grant or award | Stock Option (Right to Buy) | 21,000 | $0.00 | - | |
Item 2.02, 9.01
Item 7.01, 8.01, 9.01
Item 5.07
Item 1.02
Recent VRDN Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Tousignant Jennifer | Officer | 14,212 | $348K | View on EDGAR |
VRDN insider trading FAQ
What is the latest insider trade for VRDN?
Viridian Therapeutics, Inc.\DE (VRDN) had 2 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for VRDN runs to 26 Form 4 filings, the earliest from 2025-07-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VRDN stock?
No insider purchases of VRDN were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling VRDN stock?
2 insider sales of VRDN were filed in the last 90 days, totaling $348K.
Where can I see VRDN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VRDN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jennifer Tousignant view on EDGAR
- - Radhika Tripuraneni view on EDGAR
- - Christopher W. Cain view on EDGAR
- - Jeffrey Robert Ajer view on EDGAR
- - Jennifer K. Moses view on EDGAR
- - Sarah Gheuens view on EDGAR
- - Tomas Kiselak view on EDGAR
- - Arlene Morris view on EDGAR
- - Fairmount Funds Management LLC view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where VRDN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VRDN with a 7-day demo
- VRDN on your watchlist
- Every VRDN Form 4 filing on record
- Up to 3 months of VRDN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
